These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 37828249)
41. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
43. Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage. Unwin HJT; Mwandigha L; Winskill P; Ghani AC; Hogan AB Malar J; 2021 Nov; 20(1):438. PubMed ID: 34789253 [TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. RTS,S Clinical Trials Partnership PLoS Med; 2014 Jul; 11(7):e1001685. PubMed ID: 25072396 [TBL] [Abstract][Full Text] [Related]
48. [The RTS,S/AS01 malaria vaccine in children aged 5-17 months at first vaccination]. Vandoolaeghe P; Schuerman L Pan Afr Med J; 2018; 30():142. PubMed ID: 30374388 [TBL] [Abstract][Full Text] [Related]
49. Identification of Novel Malaria Transmission-Blocking Vaccine Candidates. Takashima E; Tachibana M; Morita M; Nagaoka H; Kanoi BN; Tsuboi T Front Cell Infect Microbiol; 2021; 11():805482. PubMed ID: 34917521 [TBL] [Abstract][Full Text] [Related]
50. Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria. Stanisic DI; Ho MF; Nevagi R; Cooper E; Walton M; Islam MT; Hussein WM; Skwarczynski M; Toth I; Good MF mBio; 2021 Oct; 12(5):e0265721. PubMed ID: 34663097 [TBL] [Abstract][Full Text] [Related]
51. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017. Dong Y; Wang L; Burgner DP; Miller JE; Song Y; Ren X; Li Z; Xing Y; Ma J; Sawyer SM; Patton GC BMJ; 2020 Apr; 369():m1043. PubMed ID: 32241761 [TBL] [Abstract][Full Text] [Related]
52. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm? Oh KB; Doherty TM; Vetter V; Bonanni P Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786 [TBL] [Abstract][Full Text] [Related]
53. The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination. Vandoolaeghe P; Schuerman L Expert Rev Vaccines; 2016 Dec; 15(12):1481-1493. PubMed ID: 27841689 [TBL] [Abstract][Full Text] [Related]
54. Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials. Agnandji ST; Fernandes JF; Bache EB; Ramharter M Future Microbiol; 2015; 10(10):1553-78. PubMed ID: 26437872 [TBL] [Abstract][Full Text] [Related]
55. Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study. Thompson HA; Hogan AB; Walker PGT; Winskill P; Zongo I; Sagara I; Tinto H; Ouedraogo JB; Dicko A; Chandramohan D; Greenwood B; Cairns M; Ghani AC Lancet Glob Health; 2022 Dec; 10(12):e1782-e1792. PubMed ID: 36400084 [TBL] [Abstract][Full Text] [Related]
56. Malaria vaccines to moderate the impact of antibiotic resistance in endemic countries. Khan M; Khan S J Med Microbiol; 2023 Jul; 72(7):. PubMed ID: 37493512 [TBL] [Abstract][Full Text] [Related]
57. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484 [TBL] [Abstract][Full Text] [Related]